The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of a subpopulation of patients with gastric cancer responsive to PARP inhibitors.
 
Simona Corso
No Relationships to Disclose
 
Annalisa Petrelli
No Relationships to Disclose
 
Sabrina Rizzolio
No Relationships to Disclose
 
Filippo Pietrantonio
Honoraria - Amgen; AstraZeneca/MedImmune; Bayer; Lilly; MSD Oncology; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; SERVIER
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Sara Bellomo
No Relationships to Disclose
 
Matteo Benelli
Consulting or Advisory Role - Novartis
 
Loris De Cecco
No Relationships to Disclose
 
Dario Romagnoli
No Relationships to Disclose
 
Violeta Serra
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - Patent based on a method to identify PARP inhibitor sensitive tumors
 
Benedetta Pellegrino
Travel, Accommodations, Expenses - Lilly; MSD; Novartis Biociencias
 
Silvia Giordano
No Relationships to Disclose